Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Upadacitinib effectively treats pyoderma gangrenosum.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

The salts have diverse molecular packing with significant hydrogen interactions.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Newly made nicotinamide compounds could potentially treat cancer.

Aumolertinib effectively controls lung cancer and improves quality of life.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Male accessory sex glands in rats rarely develop tumors and respond to hormones.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Dutasteride is approved to help manage prostate enlargement.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Finasteride slows down motherly behavior in first-time pregnant rats.

CGRP-IR axons may help maintain and renew tissues.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.